Residents in one state are facing a weighted average rate hike of 59% in 2017.
Could federal opposition to Aetna's merger with Humana destroy the crucial healthcare exchanges?
The insurer warned regulators last month that blocking its planned merger with Humana would force it to abandon the Obamacare exchanges, and now it's following through on its promise.
The Justice Department aims to block two mammoth health insurance mergers, but insurers aren't taking this rejection lying down.
Want bigger dividend payouts? These three stocks may soon oblige.
Despite its looming lawsuit with Anthem, the pharmacy benefits manager boosted its expectations for customer renewals.
Some big names in the insurance industry are waving the white flag on Obamacare.
Anthem's revenue and profit came in ahead of projections, but investors' attention is squarely focused on a new lawsuit with the DOJ.
Looking for bargains in the sector best positioned to ride aging demographic trends? These five are screaming buys.
Here's what investors will be looking for in the pharmacy benefits manager's upcoming earnings release and conference call.